Literature DB >> 15897010

Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.

Fang-Chi Lin1, Yi-Chu Chen, Funn-Juh Chen, Shi-Chuan Chang.   

Abstract

Tuberculous (TB) pleurisy and parapneumonic effusion (PPE) are common causes of pleural fibrosis. The mechanisms underlying fibrin deposition may be different since involved inflammatory cells are distinct. In this study, we measured various cytokines and fibrinolytic enzymes and compared the differences between the two effusions. PPE was further divided into noncomplicated PPE and complicated PPE/empyema subgroups. Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage inflammatory protein (MIP)-1beta, monocyte chemoattractant protein (MCP)-1, plasminogen activator inhibitor type 1 (PAI-1) and tissue type plasminogen activator (tPA) were measured using enzyme-linked immunosorbent assays. Significantly higher values of PAI-1, PAI-1/tPA ratio, IL-1beta, IL-8 and MIP-1beta and significantly lower values of TNF-alpha, IL-6 and MCP-1 were observed in PPE/empyema than in TB effusions. Compared to noncomplicated PPE, complicated PPE/empyema had significantly higher levels of TNF-alpha, IL-1beta, IL-8 and MIP-1beta. TB pleurisy patients who had higher effusion levels of TNF-alpha, IL-1beta and IL-8 were predisposing to residual pleural thickening. The underlying mechanisms of fibrin formation and deposition between the two effusions studied (PPE/empyema and TB pleurisy) could not be fully explained by the results of the present study. More studies are needed to explore this further.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897010     DOI: 10.1016/j.clim.2005.03.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients.

Authors:  Swetha Sundararajan; Subash Babu; Sulochana D Das
Journal:  Hum Immunol       Date:  2012-07-20       Impact factor: 2.850

2.  Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.

Authors:  Galina Florova; Ali O Azghani; Sophia Karandashova; Chris Schaefer; Serge V Yarovoi; Paul J Declerck; Douglas B Cines; Steven Idell; Andrey A Komissarov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

3.  Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis.

Authors:  Liliana Encinales; Joaquin Zuñiga; Julio Granados-Montiel; Maria Yunis; Julio Granados; Ingrid Almeciga; Olga Clavijo; Carlos Awad; Vilma Collazos; María Inés Vargas-Rojas; José Luis Bañales-Mendez; Lilia Vazquez-Castañeda; Joel N Stern; Viviana Romero; Masha Fridkis-Hareli; Masha Frindkis-Hareli; Daniel Terreros; Marcelo Fernandez-Viña; Edmond J Yunis
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

4.  Decreased proinflammatory cytokines production in children with complicated parapneumonic pleural effusion after intrapleural fibrinolytic treatment.

Authors:  Jieh-Neng Wang; Jyh-Wei Shin; Tsuey-Yu Chang; Jiu-Yao Wang; Jing-Ming Wu
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

5.  Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.

Authors:  Joel N H Stern; Derin B Keskin; Viviana Romero; Joaquin Zuniga; Liliana Encinales; Changlin Li; Carlos Awad; Edmond J Yunis
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  Serum amyloid alpha in parapneumonic effusions.

Authors:  Vagelis Boultadakis; Vasilis Skouras; Demosthenes Makris; Aggeliki Damianaki; Dimitrios J Nikoulis; Theodoros Kiropoulos; Smaragda Oikonomidi; Irene Tsilioni; Konstantinos Gourgoulianis
Journal:  Mediators Inflamm       Date:  2011-08-25       Impact factor: 4.711

7.  VEGF correlates with inflammation and fibrosis in tuberculous pleural effusion.

Authors:  Mauo-Ying Bien; Ming-Ping Wu; Wei-Lin Chen; Chi-Li Chung
Journal:  ScientificWorldJournal       Date:  2015-03-26

8.  HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis.

Authors:  Wei-Lin Chen; Mei-Chuan Chen; Shang-Fu Hsu; Shih-Hsin Hsiao; Chi-Li Chung
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

9.  Histone deacetylase inhibitor impairs plasminogen activator inhibitor-1 expression via inhibiting TNF-α-activated MAPK/AP-1 signaling cascade.

Authors:  Wei-Lin Chen; Joen-Rong Sheu; Che-Jen Hsiao; Shih-Hsin Hsiao; Chi-Li Chung; George Hsiao
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

10.  Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.

Authors:  Andrey A Komissarov; Galina Florova; Ali O Azghani; Ann Buchanan; Jake Boren; Timothy Allen; Najib M Rahman; Kathleen Koenig; Mignote Chamiso; Sophia Karandashova; James Henry; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.